LINNC online - The reference for Interventional NeuroRadiology, Neurology and NeuroSurgery

Come and join us across the globe

Founded by Pr. Jacques Moret

Mastering complexity in wide-neck aneurysms, dissections and intracranial stenosis

M2 thrombectomy in a 91-year-old: decision-making in a high‑risk patient

Day 2 at LINNC Americas - Innovation Across Aneurysm, Stroke, AV Shunts, and Pediatric Neurointervention

Day 1 at LINNC Americas 2026: Live from Orlando

Cases

ICA-M1 intracranial dissection EVT

February 19, 2026

Use of a unique distal-shaped microcatheter in the treatment of a wide-neck Acom aneurysm

October 27, 2025

Right MCA aneurysm treated with intrasaccular flow diversion after two failed attempts

October 20, 2025

BADDASS approach to right M1 revascularization

October 20, 2025

A must-have guide for all the neurointerventionalists

20 years of INR trials in one unique synthetic format

Get your book now

LINNC TV

Understanding neurovascular anatomy: a cornerstone of neurointervention

January 15, 2026

How can we make AVM endovascular treatment great again?

June 30, 2025

Over 100 Artisse cases: Real-world experience from Montpellier

October 10, 2025

Press releases

Acandis GmbH Announces Start of Patient Recruitment for CARESTAR Study in Symptomatic Non-stenotic Carotid Disease (SyNC)

March 4, 2026

Acandis GmbH, a leading German-based medical technology company specialising in medical devices for the treatment of neurovascular diseases, today announced the start of patient recruitment for the...

Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters

February 11, 2026

Vesalio, a global leader in vascular intervention, today announced CE Mark certification and the European commercial launch of two new neurovascular devices: NeVa™ VS, for the treatment of cerebral...

Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke

February 9, 2026

TIGERTRIEVER™ 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic...

Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology

December 12, 2025

The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio’s commercial platform.Plano, Texas – Dec 11, 2025

Congresses